A point mutation (1 277 CGG to CAG) was identified in the R-type pyruvate kinase (PK) cDNA of a PK variant, PK Sapporo, associated with hereditary non-spherocytic hemolytic anemia. The mutation causes a single amino acid substitution from Arg to Gln at the 426th amino acid residue of human R-type PK; consequently, the hydrophobicity around the mutated site is drastically decreased. The amino acid change occurred in the eighth a helix of A domain (A~r8) of PK, and it has been proposed that this region as well as
tained from Perkin Elmer Cetus (Norwalk, a). DNA was sequenced using a DNA sequencing system (Model 373A; Applied Biosystems, Foster City, CA). The computer software, DNASIS (Hitachi Software Engineering, Yokohama, Japan), was used to analyze the hydrophobicity properties of the variant protein based on the theory of Hopp and Woods."
Oligonucleotides used for cDNA cloning have been described previously.6 L 15 (S-TTACCAAGCCCCGGCCA-ACGAG-3') and L12 (5'-TAGCTCCTCAAACAGCTGC-3' ) were used for amplifying the 5' end sequences of exon 10 of the human L-PK gene. 12 cDNA synthesis. amplification, and sequencing of R-type PK mRNA. Reticulocyte RNA purification, cDNA synthesis, and amplification of the R-PK cDNA were performed as previously described! Briefly, the R-PK cDNA was synthesized using the antisense primer that was complementary to the 3' noncoding sequences of the human R-type PK mRNA and amplified by the polymerase chain reaction (PCR). The cDNAs were then subcloned into pBluescript (Stratagene). All coding and 55 bp 3' noncoding sequences were sequenced by the dideoxy method using fluorescence-labeled primers.
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Materials.
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Aa7. m 7 , and AB8 is a potassium (K+) binding site. Because K+ binding to the PK subunit is considered to be essential for substrate binding, the mutation might account for the decreased affinity for phosphoenolpyruvate (PEP). This is compatible with the fact that all the reported PK variants carrying point mutations in those area have a high Michaelis constant (Km) for PEP. 0 1993 by The American Society of Hematology.
RESULTS
IdentiJication ofa new point mutation in the R-PK cDNA of PK Sapporo. Sequencing of the R-type PK cDNA from PK Sapporo showed that the variant had a single nucleotide change at 1722 of human R-type PK cDNA, 1722 CGG --f CAG. This missense mutation caused a single amino acid substitution; 426 Arg --f Gln (R426Q), which subsequently decreased the hydrophobicity properties near the mutated site (Fig 1) . This Arg residue is well conserved during evolution, including chicken Ml-,I3 cat MI-14 and rat RI5-type PK, and is located near the amino acid array, nos. 402 through 410, that constitutes the active site of PK.I3
To confirm this nucleotide change in genomic DNAs of the patient and her mother, we amplified the 5' end region of exon 10 of the L-PK genet2 by PCR and examined the SmaI cleavage site that should be abolished by the nucleotide change. A 285-bp fragment flanking the 3' end of exon 9, intron 9, and the 5' end of exon I O was amplified by PCR. When the SmaI site is intact, the band becomes into two fragments, 237 bp and 48 bp, after SmaI digestion. As shown in Fig 2, the PCR product of the patient was resistant with the SmaI cleavage, meaning homozygous mutation. Her mother appeared to be a heterozygote, because only one PK allele was digested.
Point mutation detection in genomic DNAs.
DISCUSSION
We report here a point mutation in a Japanese PK variant; PK Sapporo. The patient has chronic hemolytic anemia, with a hemoglobin level of about 9 g/100 mL. However, blood transfusion has not been required. The enzymatic parameter 2440 KANNO, FUJII, AND MlWA 
The values in parentheses show residual PK activities after a 60-minute incubation.
Abbreviations: N, normal value; L, lower than normal; H, higher than normal; U, unstable; ST, stable; S. slow electrophoretic mobility; F. fast electrophoretic mobility.
of the variant PK was characterized by a high Michaelis constant (Km) for the substrate, phosphoenolpyruvate (PEP). low Km for adenosine diphosphate (ADP), abnormal nucleotide specificity, more adenosine triphosphate (ATP) inhibition than normal, more fructose-I. 6-diphosphate (FDP) required for 50% activation, normal thermostability. acidic optimum pH. and fast migration in polyacrylamide gel electrophoresis.'" When the biochemical characteristics of PK Sapporo were compared with the other PK variants whose mutations have already been identified in our laboratory.".' only two parameters such as a high Km for PEP and more ATP inhibition were common among those variants (Table  I) . Those characteristics are probably unfavorable for red blood cell (RBC) metabolism and would impair PK activity under physiologic PEP concentrations, resulting in hemolysis. The reported amino acid substitutions (T384M. Q42 I K, R426Q) resided in the seventh or eighth a helix of the A domain (Aa7, Aa8) of PK, deduced from the tertiary structure ofcat muscle PK.I3 These regions may be the K+ binding site of PK, and the K'-bound enzyme has an increased affinity for PEP in the presence of Mg2+.I6 The R426Q causes a profound decrease of hydrophobicity in Aa8. and the conformational change might affect the interaction of K+ to the 407th Glu. the putative amino acid residue for binding K+. A schematic presentation of the structure of the human R-type PK cDNA and location of the point mutations identified in our and other laboratories. Numbers in the cDNA shows the corresponding exon, and the bar below cDNA indicates the organization of domains, deduced from the tertiary structure of cat muscle PK.'J Closed circles indicate the amino acids constituting the active sites of PK deduced from t h e tertiary structure of cat muscle PK.
the PK variants with a single amino acid substitution in Aa7 (T384M) or Aa8 (Q42 I K). Figure 3 shows the schematic structure of human R-type PK and the position of the point mutations that are responsible for hemolytic anemia. The amino acid residues that constitute the active site of PK are located as seven clusters in the PK polypeptide. and the mutations so far identified reside within or near the active sites. Together with the tertiary structure that has been investigated in cat muscle PK,'-' the structural analysis of the mutant enzyme will provide not only some new insights in the structure-function relationship of PK but also useful information for understanding the pathogenesis of PK deficiency.
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